Large-scale testing (Phase 3)Not Yet RecruitingNCT07836283
What this trial is testing
Evaluation of the Efficacy and Safety of Bimekizumab (BZK) or Adalimumab (ADA) in the Treatment of Anterior Chest Wall Pain Associated With Active Axial Spondyloarthritis Refractory to NSAIDs With Hypothesis of Superiority of Bimekizumab
Who this might be right for
Axial or Predominantly Axial SpondyloArthritis With or Without Psoriasis
University Hospital, Rouen 150